0001209191-16-103494.txt : 20160229 0001209191-16-103494.hdr.sgml : 20160229 20160229174024 ACCESSION NUMBER: 0001209191-16-103494 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160225 FILED AS OF DATE: 20160229 DATE AS OF CHANGE: 20160229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cancelmi Daniel J CENTRAL INDEX KEY: 0001396106 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 161469944 MAIL ADDRESS: STREET 1: 13737 NOEL ROAD STREET 2: SUITE 100 CITY: DALLAS STATE: TX ZIP: 75240 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-25 0 0000070318 TENET HEALTHCARE CORP THC 0001396106 Cancelmi Daniel J 1445 ROSS AVENUE SUITE 1400 DALLAS TX 75202 0 1 0 0 Chief Financial Officer Common Stock 2016-02-25 4 M 0 8035 A 119986 D Common Stock 2016-02-25 4 F 0 3427 24.81 D 116559 D Common Stock 2016-02-25 4 M 0 13234 A 129793 D Common Stock 2016-02-25 4 F 0 5605 24.81 D 124188 D Common Stock 2016-02-26 4 M 0 7142 A 131330 D Common Stock 2016-02-26 4 F 0 3025 25.68 D 128305 D Common Stock 2016-02-26 4 M 0 14284 A 142589 D Common Stock 2016-02-26 4 F 0 6050 25.68 D 136539 D Common Stock 2016-02-26 4 M 0 7208 A 143747 D Common Stock 2016-02-26 4 F 0 3053 25.68 D 140694 D Common Stock 2016-02-26 4 M 0 7208 A 147902 D Common Stock 2016-02-26 4 F 0 3053 25.68 D 144849 D 2015 February Restricted Stock Units 2016-02-25 4 M 0 8035 0.00 D Common Stock 8035 16072 D 2015 February Performance-Based Restricted Stock Units 2016-02-25 4 M 0 13234 0.00 D Common Stock 13234 26471 D 2014 February Restricted Stock Units 2016-02-26 4 M 0 7142 0.00 D Common Stock 7142 7142 D 2014 February Performance-Based Restricted Stock Units 2016-02-26 4 M 0 14284 0.00 D Common Stock 14284 14284 D 2013 February Restricted Stock Units 2016-02-26 4 M 0 7208 0.00 D Common Stock 7208 0 D 2013 February Performance-Based Restricted Stock Units 2016-02-26 4 M 0 7208 0.00 D Common Stock 7208 0 D As previously reported, on February 25, 2015, the reporting person received a grant of 24,107 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 8,035 shares of common stock, as shown in Table I. The remaining 16,072 restricted stock units are shown in Table II, of which 8,036 are scheduled to vest on each of February 25, 2017 and February 25, 2018. Restricted stock units convert into common stock on a one-for-one basis. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. As previously reported, on February 25, 2015, the reporting person received a target grant of 24,107 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2015. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 164.7% of the target grant was awarded; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 25, 2016, resulting in the vesting and settlement of 13,234 shares of common stock, as shown in Table I. The remaining 26,471 performance restricted stock units are shown in Table II, of which 13,236 are scheduled to vest on February 25, 2017 and 13,235 are scheduled to vest on February 25, 2018. As previously reported, on February 26, 2014, the reporting person received a grant of 21,425 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015, resulting in the vesting and settlement of 7,141 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 7,142 shares of common stock, as shown in Table I. The remaining 7,142 restricted stock units are shown in Table II, which are scheduled to vest on February 26, 2017. As previously reported, on February 26, 2014, the reporting person received a target grant of 21,425 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2014. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance metric was exceeded and 200% of the target grant was awarded; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2015 resulting in the vesting and settlement of 14,282 shares of common stock. The second anniversary occurred on February 26, 2016, resulting in the vesting and settlement of 14,284 shares of common stock, as shown in Table I. The remaining 14,284 performance restricted stock units are shown in Table II, which are scheduled to vest on February 26, 2017. As previously reported, on February 28, 2013, the reporting person received a grant of 21,623 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 7,207 shares of common stock. The second vesting date occurred on February 27, 2015 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 7,208 shares of common stock. The third vesting date occurred on February 26, 2016 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 7,208 shares of common stock, as shown in Table I. As previously reported, on February 28, 2013, the reporting person received a target grant of 21,623 performance-based restricted stock units that were subject to the Company's attainment of a specified one-year performance metric for the year then-ending December 31, 2013. The performance metric was met; therefore, these restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 28, 2014, resulting in the vesting and settlement of 7,207 shares of common stock. The second vesting date occurred on February 27, 2015 (the business day prior to the anniversary date, which fell on a weekend), resulting in the vesting and settlement of 7,208 shares of common stock. The third vesting date occurred on February 26, 2016 (the business day prior to the anniversary date which fell on a weekend), resulting in the vesting and settlement of 7,208 shares of common stock, as shown in Table I. Both time-based restricted stock units and performance-based restricted stock units are settled in shares of the Company's common stock upon vesting. Anthony L. Shoemaker, as Attorney-in-Fact for Daniel J. Cancelmi 2016-02-29